[Asia Economy New York=Special Correspondent Joselgina] The advisory committee of the U.S. Centers for Disease Control and Prevention (CDC) recommended on the 4th (local time) that the pharmaceutical company Moderna's COVID-19 vaccine be formally approved.


According to CNN, the CDC's Advisory Committee on Immunization Practices (ACIP) held a meeting that day and unanimously voted to recommend that the CDC formally approve Moderna's COVID-19 vaccine for administration to adults aged 18 and over.



Earlier, the U.S. Food and Drug Administration (FDA) formally approved Moderna's COVID-19 vaccine on the 31st of last month. The brand name of Moderna's COVID-19 vaccine is 'Spikevax.'


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing